Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ I)
This study has been completed.
Sponsor:
Abbott Vascular
Information provided by:
Abbott Vascular
ClinicalTrials.gov Identifier:
NCT00148356
First received: September 6, 2005
Last updated: March 31, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2010 |
| Primary Completion Date: | May 2006 (Final data collection date for primary outcome measure) |
Publications:
Bernard Chevalier, MD., et. al. A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus-Versus Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries: The ZoMaxx I Trial. JACC: Cardiovascular Interventions. 1(5):524-32, 2008.